Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)

Completed

Conditions studied: Retinal Vein Occlusion, Macular Edema

In brief

This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there were no patient study visits. All data was collected via chart review.

Key facts

Study ID

NCT01411696

Run by

Allergan

People needed

289

Starts

2011-07-01

Expected to finish

2012-03-01

Last updated by the study team

2013-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Macular edema
• Received at least 2 OZURDEX® injections

You may not qualify if…

• Received OZURDEX® injections as part of a clinical study

Where it is running

• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.